EUROPE WESTERN BLOTTING MARKET 2019-2027

MARKET OUTLOOK
As per Triton Market Research’s estimation, the Europe western blotting market is set to display an upward trend in terms of revenue with a growth rate of 4.60% in the forecasting years from 2019-2027.
The UK, France, Spain, Italy, Russia, Germany and countries in rest of Europe together form the market for western blotting in the European region.
The German market for western blotting is growing due to the supportive government reforms which are supporting the research activities in the region. Also, the increasing number of cases of Lyme disease have increased on an average by 65% annually throughout the country based on data provided by the WHO. Thus, Europe is showcasing a high prevalence and incidence of Lyme disease, thereby raising the need for rapid diagnosis with western blotting techniques.
The rest of Europe region contains regions like the Netherlands, Switzerland and Denmark. The western blotting market is increasing rapidly in the rest of European region owing to the increase in the prevalence of new diseases, coupled with the rise in R&D investments in the region. According to the Health Insurance Act, all residents of the Netherlands are obliged to have health insurance. The legislation prohibits insurance companies from declining health insurance for persons (including HIV-infected individuals) who are legally entitled/obliged to be insured. The Netherlands has a system where health insurers are compensated for predictable healthcare cost of their insured portfolio. Therefore, the increase in care and treatment of the disease is helping the market to grow in the region.
COMPETITIVE OUTLOOK
Some of the established giants in the market are Advansta, Azure Biosystems, Inc., PerkinElemer, Inc., Roche Diagnostics International, Inc., Roche Diagnostics, Lumigen, Inc. and Rockland Immunochemicals, Inc.

TABLE OF CONTENT
1. EUROPE WESTERN BLOTTING MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. GROWING NUMBER OF APPLICATIONS FOR WESTERN BLOTTING
2.2.2. GROWING ACCEPTANCE OF DIGITAL WESTERN BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3. WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4. WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5. WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6. WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. EUROPE
6.1.1. UNITED KINGDOM
6.1.2. GERMANY
6.1.3. FRANCE
6.1.4. SPAIN
6.1.5. ITALY
6.1.6. RUSSIA
6.1.7. REST OF EUROPE
7. COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC, INC.
7.4. BIO-RAD TECHNOLOGIES, INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY, INC.
7.7. GE HEALTHCARE
7.8. LI-COR, INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS, INC.
7.11. PERKINELEMER, INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL, INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN, INC.
7.15. ROCKLAND IMMUNOCHEMICALS, INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY



LIST OF TABLES
TABLE 1. EUROPE WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. EUROPE WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 5. EUROPE WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 6. EUROPE WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)
TABLE 7. EUROPE WESTERN BLOTTING MARKET, BY END-USER, 2019-2027 (IN $ MILLION)



LIST OF FIGURES
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. EUROPE WESTERN BLOTTING MARKET, BY CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 3. EUROPE WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS, 2019-2027 (IN $ MILLION)
FIGURE 4. EUROPE WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $ MILLION)
FIGURE 5. EUROPE WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES, 2019-2027 (IN $ MILLION)
FIGURE 6. EUROPE WESTERN BLOTTING MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 7. EUROPE WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. EUROPE WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 9. EUROPE WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 10. EUROPE WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. EUROPE WESTERN BLOTTING MARKET, BY WET BLOTTING SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. EUROPE WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 13. EUROPE WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. EUROPE WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 15. EUROPE WESTERN BLOTTING MARKET, BY OTHER IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 16. EUROPE WESTERN BLOTTING MARKET, BY BIOMEDICAL & BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. EUROPE WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 18. EUROPE WESTERN BLOTTING MARKET, BY AGRICULTURE, 2019-2027 (IN $ MILLION)
FIGURE 19. EUROPE WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS, 2019-2027 (IN $ MILLION)
FIGURE 20. EUROPE WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)
FIGURE 21. EUROPE WESTERN BLOTTING MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. EUROPE WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS, 2019-2027 (IN $ MILLION)
FIGURE 23. EUROPE WESTERN BLOTTING MARKET, BY OTHER END-USERS, 2019-2027 (IN $ MILLION)
FIGURE 24. EUROPE WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 25. UNITED KINGDOM WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26. GERMANY WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27. FRANCE WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 28. SPAIN WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29. ITALY WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 30. RUSSIA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 31. REST OF EUROPE WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)